1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Subcutaneous Markets for Biotherapeutics

Subcutaneous Markets for Biotherapeutics

  • December 2015
  • -
  • Greystone Research Associates


In recent years, the number of biological drugs in development and reaching the marketplace has increased significantly. The clinical application of these drugs is sometimes limited by a lack of desirable attributes relative to market needs and opportunities. To realize the full therapeutic and commercial potential of biologicals, drug developers and technologists are applying a number of innovative solutions which are aimed at addressing the limitations of biological drugs one by one. Initiatives include formulation techniques, drug processing strategies and subcutaneous injection device design and customization. These technologies are addressing a range of issues that include drug stability, physical properties, drug release profiles and dosing volumes, factors that can directly affect the ability of drugs to be administered subcutaneously.

What You Will Learn

- What are the major limitations holding back the trend toward self administration of biotherapeutic drugs?
- What are the technology initiatives and solutions being applied to biotherapeutic drugs and drug candidates to enable their delivery via subcutaneous injection?
- Who are the important technology suppliers, their capabilities, and their drug development partners?
- What is the market for subcutaneous biotherapeutics today? What will it be in 2022?
- How important are drug developer-technology partner relationships to commercial success?
- What are the essential design factors, technologies and market development issues for increasing the commercial potential of biotherapeutic drugs?
- How are biotherapeutic technology solutions aligned with various drug classes and therapeutic markets?
- What are the significant economic, technology, and regulatory factors affecting subcutaneous biotherapeutics?

Table Of Contents

Subcutaneous Markets for Biotherapeutics
Executive Summary

Therapeutic Biologicals - Challenges and Risks
The Biological Therapeutics Market Space
Drug Properties - Limits and Constraints
Half?Life and Therapeutic Protocols
Dug Viscosities
Drug Volumes
Market Sector Demand Drivers
Diseases and Indications
Patient Population Demographics
Access and Reimbursement
Developing Economies
Biotherapeutics - The Competitive Landscape

Biotherapeutics Administration - Product Strategies
Processing Strategies
Dual Chamber Devices
Custom Recon Systems
Third Party Recon Solutions
Formulation Strategies
Extended/Sustained Release
Biodegradable Polymers
Delivery Device Strategies
High Visc Autoinjectors
Wearable SC Infusion Devices
Large Volume Injectors
Other Device Classes

Subcutaneous Biotherapeutics - The Current Market
Growth Factors
Immune Modulators
Other Protein Therapy Classes

Biotherapeutic Market Segments - Analysis, Market Data and Forecasts
Autoimmune Diseases
Blood Factors and Hematopoietics
Hormone Replacement
Infectious Diseases
Metabolic Diseases
Reproductive Health
Respiratory Conditions
Orphan Diseases

Biotherapeutics - Commercialization and Market Factors
Regulatory Factors and Issues
Managed Care and Healthcare Economics

Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Cell Therapy Manufacturing Market, 2017-2027

Cell Therapy Manufacturing Market, 2017-2027

  • $ 2499
  • Industry report
  • March 2017
  • by Roots Analysis Private Ltd.

The “Cell Therapy Manufacturing Market, 2017-2027” report provides an extensive study of the rapidly growing market of cell therapy manufacturing and focuses both on contract manufacturers and cell ...

Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Pipeline and Market Analysis, 2017

Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Pipeline and Market Analysis, 2017

  • $ 2750
  • Industry report
  • March 2017
  • by Delve Insight

DelveInsight’s, “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline ...

Global Human Embryonic Stem Cell (hESC) Research - Biotechnology

Global Human Embryonic Stem Cell (hESC) Research - Biotechnology

  • $ 4200
  • Industry report
  • February 2017
  • by Global Industry Analysts

This report analyzes the Global market for Human Embryonic Stem Cell (hESC) Research in US$ Million. Annual estimates and forecasts are provided for the period 2014 through 2022. Market data and analytics ...

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Industry in Canada

  • December 2016
    7 pages
  • Biological Ther...  


  • Canada  

View report >

Biological Therapy Industry in the UK - Forecast

  • April 2016
    18 pages
  • Tissue Engineer...  

    Cell Therapy  

    Gene Therapy  

  • United Kingdom  


View report >

The future of the Cell Therapy Industry in Japan and the US

  • March 2017
    4 pages
  • Cell Therapy  



  • Japan  

    United States  

View report >

Related Market Segments :



Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.